Chinese medical facility advocates for non-radiative therapy in treating heart conditions
Fuwai Hospital, affiliated with the Chinese Academy of Medical Sciences, has extensively implemented a radiation-free ultrasound-guided treatment for heart disease. This minimally invasive approach provides safer options for a range of patients and seeks to enhance worldwide access to cardiovascular care.
TroibNews 
Fuwai Hospital, a leading cardiovascular care facility under the Chinese Academy of Medical Sciences, has introduced a groundbreaking radiation-free percutaneous intervention for heart disease treatment.
This innovative approach utilizes ultrasound imaging to guide the minimally invasive placement of instruments through peripheral blood vessels directly into the heart.
In contrast to conventional methods, this technique does not require surgery or radiation, allowing patients to remain awake during the procedure. It is particularly beneficial for pregnant women, individuals with allergies, and cancer patients, as it mitigates the risks associated with radiation exposure. Additionally, the procedure does not rely on expensive imported equipment, enhancing its accessibility and technical feasibility.
To date, Fuwai Hospital has developed more than 17 new treatments for various cardiovascular conditions, including congenital heart disease, valvular disease, and arrhythmia, resulting in the acquisition of 65 patents. In the realm of technological advancements, the hospital has created several therapeutic instruments, such as an ultrasonic catheter and a surgical robot, with 23 of these devices now available in both domestic and international markets.
The newly developed procedure is anticipated to strengthen the capabilities of primary healthcare services, allowing for effective outpatient treatments for heart disease. This advancement is set to broaden access to cardiac care in regions and countries where medical resources are limited. Notably, this form of heart treatment has garnered support from the United Nations.
Moreover, medical teams from Fuwai Hospital have been engaging in international outreach, bringing Chinese cardiovascular treatment options to more than 30 countries, including France, Germany, Canada, Russia, and Kenya.
Lucas Dupont for TROIB News
This innovative approach utilizes ultrasound imaging to guide the minimally invasive placement of instruments through peripheral blood vessels directly into the heart.
In contrast to conventional methods, this technique does not require surgery or radiation, allowing patients to remain awake during the procedure. It is particularly beneficial for pregnant women, individuals with allergies, and cancer patients, as it mitigates the risks associated with radiation exposure. Additionally, the procedure does not rely on expensive imported equipment, enhancing its accessibility and technical feasibility.
To date, Fuwai Hospital has developed more than 17 new treatments for various cardiovascular conditions, including congenital heart disease, valvular disease, and arrhythmia, resulting in the acquisition of 65 patents. In the realm of technological advancements, the hospital has created several therapeutic instruments, such as an ultrasonic catheter and a surgical robot, with 23 of these devices now available in both domestic and international markets.
The newly developed procedure is anticipated to strengthen the capabilities of primary healthcare services, allowing for effective outpatient treatments for heart disease. This advancement is set to broaden access to cardiac care in regions and countries where medical resources are limited. Notably, this form of heart treatment has garnered support from the United Nations.
Moreover, medical teams from Fuwai Hospital have been engaging in international outreach, bringing Chinese cardiovascular treatment options to more than 30 countries, including France, Germany, Canada, Russia, and Kenya.
Lucas Dupont for TROIB News
